Business
Organigram Announces Results of 2017 Annual & Special Meeting
Organigram Announces Results of 2017 Annual & Special Meeting Organigram Annou...
About this update from Organigram Global Inc.
[{"type":"text","content":"\n\n\n\nOrganigram Announces Results of 2017 Annual & Special Meeting\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nOrganigram Announces Results of 2017 Annual & Special Meeting\nCanada NewsWire\nMONCTON, NB, Dec. 20, 2017\n\n\n\nMONCTON, NB, Dec. 20, 2017 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF) (the \"Company\" or \"Organigram\"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, announces the results of its 2017 Annual and Special Meeting of Shareholders (the \"Meeting\") held Tuesday, December 19, 2017 in Moncton.\n\n\n \n \n\n \nShareholders voted to elect all six of management's nominees to the Board of Directors of the Company, being returning directors Peter Amirault, Denis Arsenault, Michel Bourque, Greg Engel and Dr. Kenneth Mitton, as well as management nominee Derrick West. All directors are \"independent\" as defined under securities laws, excepting Denis Arsenault and Greg Engel.\n\nShareholders also approved the following matters:\n\n\nRe-appointment of Deloitte LLP as the auditors for the Company for the ensuing year;\nThe continuation of the Company's 10% \"rolling\" share option plan; and\nThe ratification and approval, by resolution of the disinterested shareholders of the Company, of the Equity Incentive Plan (as described in the Meeting circular), which remains subject to TSXV approval.\n\nAll matters passed with an approval rate in excess of 90% of shares voted.\n\nSubsequent to the Meeting, the newly-elected board of directors of Organigram (the \"Board\") appointed Denis Arsenault as Chairman of the Board and Peter Amirault as the Lead Director. \n\nThe Board also appointed Derrick West as the Chair of the Audit Committee for the ensuing year.  Mr. West currently serves as the Chief Financial Officer and Corporate Secretary of Partners Real Estate Investment Trust, a TSX listed issuer, and has previously served as the CFO of a TSXV listed international mining service enterprise and as the Vice-President of Accounting and Administration for a TSX listed REIT.  Mr. West comm...